Actinium Pharmaceuticals Inc (ATNM): Next-Year EPS Estimate 26.37%
As of 2026-07-17, Actinium Pharmaceuticals Inc (ATNM) has a next-year EPS growth estimate of 26.37%.
On 2026-07-16, analyst consensus for ATNM's next-year EPS growth shifted from 42.14% to 26.37% — a negative change of 15.77 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at 16.51%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 26.37%
- EPS growth this year
- 16.51%
- EPS next quarter (est)
- -$0.20
- Last price
- $0.92
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-17 | 26.37% | 16.51% | -$0.20 | $0.92 |
| 2026-07-16 | 26.37% | 16.51% | -$0.20 | $0.89 |
| 2026-03-25 | 42.14% | N/A | N/A | $1.08 |
| 2026-03-24 | 42.14% | N/A | N/A | $1.07 |
| 2026-03-24 | 42.14% | N/A | N/A | $1.07 |
| 2026-03-24 | 42.14% | N/A | N/A | $1.07 |
| 2026-03-23 | 42.14% | N/A | N/A | $1.14 |
| 2026-03-20 | 42.14% | N/A | N/A | $1.11 |
| 2026-03-19 | 42.14% | N/A | N/A | $1.09 |
| 2026-03-18 | 42.14% | N/A | N/A | $1.10 |
| 2026-03-17 | 42.14% | N/A | N/A | $1.14 |
Screen Performance
Aggregate stats across all 1864 tickers our top-EPS-revision screen has flagged over the past 107 days.
- Median return since detection
- +2.5%
- % of tickers in the green
- 55%
- Median return on winners
- +20.8%
- Large revisions captured
- 1048
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Actinium Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-07-17, Actinium Pharmaceuticals Inc (ATNM) has a next-year EPS growth estimate of 26.37%, based on analyst consensus.
When was the latest EPS estimate revision for ATNM?▾
The most recent revision occurred on 2026-07-16, when analysts adjusted the next-year EPS growth estimate from 42.14% to 26.37%.
What sector and industry does Actinium Pharmaceuticals Inc belong to?▾
Actinium Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ATNM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Actinium Pharmaceuticals Inc (ATNM) appears here because it was detected by our daily top-EPS-revision-performer screen.